Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor suppressor gene p16/INK4A/CDKN2A-dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer.
Agarwal P, Sandey M, DeInnocentes P, Bird RC. Agarwal P, et al. Among authors: deinnocentes p. J Cell Biochem. 2013 Jun;114(6):1355-63. doi: 10.1002/jcb.24476. J Cell Biochem. 2013. PMID: 23238983
Characterization of the CDP-like/CTAS-1 binding site in the okadaic acid response element (OARE) of the human CDK1(p34cdc2) promoter.
Bird RC, Deinnocentes P. Bird RC, et al. Among authors: deinnocentes p. Anticancer Res. 2004 May-Jun;24(3a):1469-80. Anticancer Res. 2004. PMID: 15274312
Alterations in CDK1 expression and nuclear/nucleolar localization following induction in a spontaneous canine mammary cancer model.
Migone F, Deinnocentes P, Smith BF, Bird RC. Migone F, et al. Among authors: deinnocentes p. J Cell Biochem. 2006 Jun 1;98(3):504-18. doi: 10.1002/jcb.20707. J Cell Biochem. 2006. PMID: 16317763
An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.
Bird RC, Deinnocentes P, Lenz S, Thacker EE, Curiel DT, Smith BF. Bird RC, et al. Among authors: deinnocentes p. Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):289-304. doi: 10.1016/j.vetimm.2008.02.013. Epub 2008 Feb 26. Vet Immunol Immunopathol. 2008. PMID: 18423623 Clinical Trial.
Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
DeInnocentes P, Agarwal P, Bird RC. DeInnocentes P, et al. J Cell Biochem. 2009 Feb 15;106(3):491-505. doi: 10.1002/jcb.22034. J Cell Biochem. 2009. PMID: 19130492
Expression and sequence of canine SIRT2 and p53 genes in canine mammary tumour cells - effects on downstream targets Wip1 and p21/Cip1.
DeInnocentes P, Li LX, Sanchez RL, Bird RC. DeInnocentes P, et al. Vet Comp Oncol. 2006 Sep;4(3):161-77. doi: 10.1111/j.1476-5829.2006.00105.x. Vet Comp Oncol. 2006. PMID: 19754813
Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency.
Jayanna PK, Bedi D, Gillespie JW, DeInnocentes P, Wang T, Torchilin VP, Bird RC, Petrenko VA. Jayanna PK, et al. Among authors: deinnocentes p. Nanomedicine. 2010 Aug;6(4):538-46. doi: 10.1016/j.nano.2010.01.005. Epub 2010 Feb 4. Nanomedicine. 2010. PMID: 20138246 Free PMC article.
Landscape phage ligands for PC3 prostate carcinoma cells.
Jayanna PK, Bedi D, Deinnocentes P, Bird RC, Petrenko VA. Jayanna PK, et al. Among authors: deinnocentes p. Protein Eng Des Sel. 2010 Jun;23(6):423-30. doi: 10.1093/protein/gzq011. Epub 2010 Feb 25. Protein Eng Des Sel. 2010. PMID: 20185523 Free PMC article.
Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes.
Bedi D, Musacchio T, Fagbohun OA, Gillespie JW, Deinnocentes P, Bird RC, Bookbinder L, Torchilin VP, Petrenko VA. Bedi D, et al. Among authors: deinnocentes p. Nanomedicine. 2011 Jun;7(3):315-23. doi: 10.1016/j.nano.2010.10.004. Epub 2010 Nov 2. Nanomedicine. 2011. PMID: 21050894 Free PMC article.
An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.
Bird RC, Deinnocentes P, Church Bird AE, van Ginkel FW, Lindquist J, Smith BF. Bird RC, et al. Among authors: deinnocentes p. Cancer Immunol Immunother. 2011 Jan;60(1):87-97. doi: 10.1007/s00262-010-0921-2. Epub 2010 Nov 11. Cancer Immunol Immunother. 2011. PMID: 21069323
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback